This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2017 Dec 1;2(12):1298-1299.

doi: 10.1001/jamacardio.2017.3656.

Cost-effectiveness of PCSK9 Inhibitors: Proof in the Modeling

Robert O Bonow^{1

2}, Robert A Harrington^{3

4}, Clyde W Yancy^{3

4}

Affiliations

Affiliations

¹ Northwestern University Feinberg School of Medicine, Chicago, Illinois.
² Editor.
³ Department of Medicine, Stanford University, Stanford, California.
⁴ Deputy Editor.

PMID: 29049827
DOI: 10.1001/jamacardio.2017.3656

Editorial

Cost-effectiveness of PCSK9 Inhibitors: Proof in the Modeling

Robert O Bonow et al. JAMA Cardiol. 2017.

. 2017 Dec 1;2(12):1298-1299.

doi: 10.1001/jamacardio.2017.3656.

Authors

Robert O Bonow^{1

2}, Robert A Harrington^{3

4}, Clyde W Yancy^{3

4}

Affiliations

¹ Northwestern University Feinberg School of Medicine, Chicago, Illinois.
² Editor.
³ Department of Medicine, Stanford University, Stanford, California.
⁴ Deputy Editor.

PMID: 29049827
DOI: 10.1001/jamacardio.2017.3656

No abstract available

PubMed Disclaimer

Comment on

Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease.
Fonarow GC, Keech AC, Pedersen TR, Giugliano RP, Sever PS, Lindgren P, van Hout B, Villa G, Qian Y, Somaratne R, Sabatine MS. Fonarow GC, et al. JAMA Cardiol. 2017 Oct 1;2(10):1069-1078. doi: 10.1001/jamacardio.2017.2762. JAMA Cardiol. 2017. PMID: 28832867 Free PMC article.
Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers: Insights Derived From the FOURIER Trial.
Arrieta A, Hong JC, Khera R, Virani SS, Krumholz HM, Nasir K. Arrieta A, et al. JAMA Cardiol. 2017 Dec 1;2(12):1369-1374. doi: 10.1001/jamacardio.2017.3655. JAMA Cardiol. 2017. PMID: 29049467 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal